Orgenesis Announces Planned Study to Confirm Suitability of Liver Cells as a Source for Personalized Cell Replacement Therapy for Insulin-Dependent Diabetic Patients

Stock Information for Orgenesis Inc.

Loading

Please wait while we load your information from QuoteMedia.